By LifETIME CDT Student: Hannah Williamson (University of Birmingham) Cell therapies, medicines made from human cells, have had huge success in fighting leaukemias and offer new hope to patients as treatments for a range of diseases. However, the manufacture of these therapies remains a major challenge and barrier to patient access. New technologies are …
By lifETIME CDT Administrator: Emma Lardner (University of Birmingham) Professor Alicia El Haj, Interdisciplinary Chair of Cell Engineering at the University of Birmingham and LifETIME CDT supervisor has won a Midlands Women in Tech Academic Award. Professor El Haj is a leading figure working within the field of healthcare technologies. She has been making signification contributions with …
By LifETIME CDT Student: Chloe Wallace (University of Glasgow) From jelly to contact lenses – hydrogels are all around us. In fact, with the exception of our teeth and bones, most of our body is composed of hydrogels. With that in mind, it seems obvious to explore the potential of these gels as biomaterials. In my …
By LifETIME CDT Student: Aoibhin Sheedy (NUI Galway) Immunotherapy is a promising approach for breakthrough therapies in the treatment of ovarian cancer, but there needs to be a robust investigation into suitable targets and delivery methods to solidify its true value for patients and clinicians. Ovarian cancer is the fourth leading cause of death due …
By Emma Lardner and LifETIME CDT Student: Abigail Wright (University of Birmingham) Abigail Wright is a second year LifETIME CDT student studying the control of ECM organization and the mechanical environment in a ‘Joint on a chip’ device at the University of Birmingham. Abi recently signed up for the In2Science mentoring scheme, which provides students from …
By LifETIME CDT Student: Chanelle McGuinness (University of Glasgow) Bone marrow is a complex organ that is home to numerous cell populations. Haematopoietic stem cells (HSCs) in the bone marrow are responsible for specialising and becoming all blood cell types – a process known as haematopoiesis. They are also the basis for HSC transplants for patients …